<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0001890'>Autoimmune hemolytic anemia</z:hpo> (AIHA) rarely occurs in <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>A 36-year-old Asian female was diagnosed with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> (refractory cytopenia with multilineage <z:mpath ids='MPATH_589'>dysplasia</z:mpath>, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RCMD</z:e>) and complicated by AIHA 7 months later </plain></SENT>
<SENT sid="2" pm="."><plain>Secondary <z:hpo ids='HP_0011974'>myelofibrosis</z:hpo> developed at the same time </plain></SENT>
<SENT sid="3" pm="."><plain>Steroid therapy was ineffective and <z:chebi fb="0" ids="4031">cyclosporin A</z:chebi> (CsA) was discontinued due to its neurotoxicity with the development of <z:hpo ids='HP_0002352'>leukoencephalopathy</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>However, the patient achieved a good hematological response after the use of <z:chebi fb="0" ids="168396">mycophenolate</z:chebi> mofetil (MMF, CellCept) with a dose of 1 g/day and <z:chebi fb="2" ids="8378">prednisolone</z:chebi> (15 mg/day) </plain></SENT>
<SENT sid="5" pm="."><plain><z:chebi fb="2" ids="8378">Prednisolone</z:chebi> was tapered off over the next 3 weeks </plain></SENT>
<SENT sid="6" pm="."><plain>The patient did not require any blood support 4 weeks after the use of MMF and has been hematologically stable for 4 months </plain></SENT>
<SENT sid="7" pm="."><plain>To our knowledge, this is the first report of using MMF in treating <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> complicated by AIHA </plain></SENT>
<SENT sid="8" pm="."><plain>MMF might be considered as a salvage therapy for patients with <z:hpo ids='HP_0005505'>refractory anemia</z:hpo> complicated by AIHA </plain></SENT>
</text></document>